Showing results 1 to 2 of 2
[Differentiating effect of PPARgamma ligand rosiglitazone and all trans-retinoic acid on myeloma cells and its possible mechanism].
Journal:Zhonghua zhong liu za zhi [Chinese journal of oncology]
Rosiglitazone and all-trans retinoic acid inhibit human myeloma cell proliferation via apoptosis signaling pathway modulation
Journal:Zhonghua Xue Ye Xue Za Zhi